Search Job Title Only
News By Subject
News by Disease
News By Date
Get Our FREE
Recalls Skin Infection Drug, Sotret in the U.S.
11/20/2009 7:13:11 AM
Business-Standard.com -- India’s leading drug maker Ranbaxy has initiated a voluntary recall of 4,348 cartons of its skin infection drug Sotret (isotretinoin) in the United States. The entire lot pertains to a single batch of tablets which were found to be ‘out of specification’.
Issues Will Take Long Time to Resolve
Biogen Idec, Inc. (California)
) Tysabri, the MS Drug Haunted by Deadly Side Effect, Doesn't Look So Deadly Anymore
Response on Drug Ban "Very Soon"
The Danger Of Marketing Prescription Drugs Online
Gets Final U.S. Nod for Migraine Drug
Drug Therapy More Cost-Effective Than Angioplasty for Diabetic Patients with Heart Disease,
Stanford University School of Medicine
Pharma Stocks Jump with Swine Flu Panacea,
Strides Arcolab Limited
Express Readiness to Meet Demand
Isis Pharmaceuticals, Inc.
) Spinoff With Anti-Scarring Drug, Marches Ahead in Clinical Trials
Generic Drug Plant,
Caught Falsifying Data
Fibrocell Science, Inc.
Reports Outcome of
Advisory Committee Meeting on Azfibrocel-T for Wrinkles
comments powered by Disqus.
comments powered by
Ranbaxy Laboratories Limited
Clinical - Recalls and Warnings
Clinical - Drug Product News
Clinical - Drug Product News (World)
Clinical - Recalls and Warnings (World)